Evidence map›Paper›PMID 11876758›Full record

ArticleClinical and experimental immunology2002

Interleukin-1 receptor antagonist gene polymorphism and mortality in patients with severe sepsis.

F Arnalich, D López-Maderuelo, R Codoceo, J Lopez, L M Solis-Garrido, C Capiscol, C Fernandez-Capitán, R Madero, C Montiel

Registry-linked trialOpen access · greenAbstract readComparative Study
In one paragraph

Article in Clinical and experimental immunology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00732277 (Evaluation of Corticosteroid Therapy in Childhood Severe Sepsis), which is not on this map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00732277 phase2completednot on this mapstarted 2008, after this paper: background citation

Evaluation of Corticosteroid Therapy in Childhood Severe Sepsis (Steroids in Paediatric Sepsis, StePS) - a Randomised Pilot Study

TypeinterventionalSponsorUniversity Hospital Southampton NHS Foundation TrustRan2008 to 2012Enrolled21ConditionsSepsisArmshydrocortisone
3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 122 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. The rs8506 TT Genotype inFrontiers in public health · 2022
    Article
  6. Genetic Sequence Variants inChildren (Basel, Switzerland) · 2020
    Article
  7. Cells · 2020
    Review
  8. Cytokine storm and sepsis disease pathogenesis.Seminars in immunopathology · 2017
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Genetic polymorphisms and posttraumatic complications.Comparative and functional genomics · 2010
    Article
  18. Article
  19. Article
  20. Interleukin-1 receptor antagonist intron 2 variable number of tandem repeats polymorphism and respiratory failure in children with community-acquired pneumonia.Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies · 2008
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

F ArnalichDepartment of Medicine, Hospital La Paz, Universidad Autónoma de Madrid, Spain. francisco.arnalich@uam.es
D López-Maderuelo
R Codoceo
J Lopez
L M Solis-Garrido
C Capiscol
C Fernandez-Capitán
R Madero
C Montiel
Universidad Autónoma de Madrid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aims to determine the influence of the polymorphism within the intron 2 of the interleukin-1 receptor antagonist gene (IL-1RN*) on the outcome of severe sepsis, and to assess its functional significance by correlating this polymorphism with the total production of interleukin-1 receptor antagonist (IL-1Ra) protein determined in stimulated peripheral blood mononuclear cells (PBMC). A group of 78 patients with severe sepsis (51 survivors and 27 nonsurvivors) was compared with a healthy control group of 130 blood donors, and 56 patients with uncomplicated pneumonia. We found a significant association between IL-1RN* polymorphism and survival. Thus, after adjusting for age and APACHE II score, multiple logistic regression analysis showed that patients homozygotes for the allele *2 had a 6.47-fold increased risk of death (95% CI 1.01--41.47, P = 0.04). Besides, compared with patients homozygous or heterozygous for the allele *1, IL-1RN*2 homozygotes produced significantly lower levels of IL-1Ra from their PBMC. Our results suggest that insufficient production of this cytokine might contribute, among other factors, to the higher mortality rate found in severe sepsis patients with the IL-1RN*2 homozygous genotype.

Indexed as

Polymorphism, GeneticAdultAgedAllelesAPACHECohort StudiesFemaleGenetic Predisposition to DiseaseGenotypeHumansInterleukin 1 Receptor Antagonist ProteinMaleMiddle AgedRegression AnalysisSepsisSialoglycoproteinsIL1RN protein, humanInterleukin 1 Receptor Antagonist ProteinSialoglycoproteins

Identifiers

PMID11876758
PMCPMC1906336
OpenAlexW2060034321

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.